Paul Lubock

Laguna Niguel, CA, United States of America

Paul Lubock

Average Co-Inventor Count = 3.2

ph-index = 62

Forward Citations = 15,056(Granted Patents)

Forward Citations (Not Self Cited) = 12,716(Sep 21, 2024)

DiyaCoin DiyaCoin 33.37 

Inventors with similar research interests:


Location History:

  • Laguna Niquel, CA (US) (2001 - 2012)
  • Laguna Niguel, CA (US) (1992 - 2019)
  • Monarch Beach, CA (US) (2013 - 2024)
  • Laguna NiguelMonarch Beach, CA (US) (2024)


Years Active: 1992-2025

where 'Filed Patents' based on already Granted Patents

208 patents (USPTO):
24 patents (CIPO):

Title: Paul Lubock: Revolutionizing Medical Device Sealing with Innovative Hemostasis Valves

Introduction:

In the realm of medical device innovation, there are a few extraordinary individuals who make a lasting impact through their groundbreaking creations. One such remarkable inventor is Paul Lubock, based in Laguna Niguel, CA (US). With an impressive portfolio of 191 patents, Lubock's exceptional contributions have transformed the field of medical devices and particularly shaped the development of hemostasis valves.

Latest Patents:

Lubock's latest patents focus on the development of cutting-edge devices, systems, and methods for sealing medical instruments, predominantly during intravascular access procedures. These inventions address the critical need for efficient, reliable, and adaptable hemostatic valves to seal a wide range of medical devices, including catheters, wires, and embolectomy systems.

The hemostasis valve, as created by Lubock, consists of an elongated member with a central lumen extending between its two ends. A reinforcement structure, coupled to the elongate member, enhances its durability. Additionally, a shell with two apertures, fluidly connected by the elongate member, provides sealing capabilities. The valve also incorporates a tensioning mechanism that allows for the controlled opening and closing of the central lumen.

Career Highlights:

Throughout his illustrious career, Paul Lubock has made significant contributions to the medical device industry. Among the companies he has worked with, two noteworthy collaborations stand out: Senorx, Inc. and Inari Medical, Inc. As part of these organizations, Lubock has contributed to their cutting-edge research and development efforts, focusing on improving patient outcomes through innovative medical devices.

Collaborations:

Lubock has had the privilege of collaborating with several accomplished individuals, including Michael Jones and Richard Quick. These collaborations have proven instrumental in advancing the field of hemostasis valve technology by fostering a dynamic exchange of ideas and expertise.

Conclusion:

In the world of medical device innovation, Paul Lubock emerges as a pioneering force revolutionizing the design and functionality of hemostasis valves. His extensive patent portfolio, including his latest inventions, showcases Lubock's commitment to improving patient care through innovative and versatile sealing devices. With his collaborations and contributions to notable companies like Senorx, Inc. and Inari Medical, Inc., Lubock's impact is felt across the industry. As we look towards the future, his work provides a solid foundation for further advancements in medical device technology, benefiting patients and healthcare professionals alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…